---
$id: https://graph.org.ai/products/commodity/51284149
$type: Product
source: UNSPSC
code: "51284149"
title: "Ceftizoxime sodium"
class: "51284100"
classTitle: "Third generation cephalosporins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ceftizoxime sodium

**UNSPSC Code**: 51284149
**Class**: [Third generation cephalosporins](Third generation cephalosporins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cephalosporin antibiotic with the molecular formula C13H12N5O5S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 26337D5X88, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)-(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt, (6r-(6-alpha,7-beta(z)))- but more generally known as ceftizoxime sodium, which bears US NIH Compound Identifier 9570777. European Medicines Agency schedules Ceftizoxime sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01137MIG. Most nations, for tariff and trade purposes, schedule ceftizoxime sodium under HS 29419000 and SITC 54139. As of Q4 2014, CEFTIZOXIME SODIUM remains US FDA's Preferred Term for this commodity. Ceftizoxime sodium bears US NLM identifiers UMLS ID C0282391 and NCI Concept Code C47438. SMILES: CO/N=C(/C1CSC(N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)[O-].[NA+].

